News

This study explores how activity monitoring mobile apps and software impact overall health outcomes in PWT2, focusing on both physical and mental well-being.

This study assesses how third-party digital health apps (those not specifically tied to a diabetes device) impact glycemic control, mental well-being, and BMI. ‍

This study examines how patient trust in AID systems correlates with the perceived effectiveness of the system and how they alleviate diabetes management burdens.

dQ&A presented three research abstracts at ATTD 2025, an academic and professional conference of innovation and advancement in diabetes devices. 

Unreliable respondents are the scourge of consumer panels. Our data shows that cheaters and bots typically represent the majority of commercially available diabetes patient sample. We routinely see them in healthcare provider sample as well.

Our Qual team has conducted thousands of interviews with patients and medical professionals. We map patient journeys, test and refine diabetes devices in development, assess communication effectiveness and uncover prescribing drivers and barriers.

Our latest Diabetes Drug Insights study follows a group of more than n=3,000 people with type 2 diabetes in the USA from 2018 to 2024.

The latest data in our current survey highlights geographical differences in the comorbidities experienced by people with diabetes along with satisfaction with their glucose control.